How Much Does Spironolactone Cost in Illinois in 2026?

Illinois Cash-Pay Prices for Spironolactone in 2026

A 30-day supply of generic spironolactone 50 mg or 100 mg tablets averages about $15 across Illinois retail pharmacies without any insurance applied. That figure places Illinois roughly in line with national averages for this generic, which has been off-patent for decades. Pfizer's branded Aldactone carries a list price near $80 per month, but very few patients or pharmacies dispense the brand when a generic costs a fraction of that amount.

Prices can swing by $5 to $10 depending on which pharmacy fills the script. Large chains such as Walgreens (headquartered in Deerfield, IL), CVS, and Walmart tend to cluster around the $9, $18 range for a 30-day supply at the 50 mg and 100 mg strengths. Independent pharmacies in downstate Illinois sometimes price slightly higher due to lower dispensing volume. Costco pharmacies in the Chicago metro area have historically offered some of the lowest cash prices for generics, and spironolactone is no exception.

For patients paying out of pocket, free discount tools like GoodRx, RxSaver, and SingleCare can push the price below $10 at participating locations. Because spironolactone is already inexpensive as a generic, these coupons may save only a few dollars, but for patients on fixed incomes or those filling multiple prescriptions, small savings compound. The 25 mg tablet is typically the cheapest per-unit, though patients prescribed 100 mg daily may pay less per milligram with the 100 mg tablet than by splitting or doubling 25 mg or 50 mg pills.

Spironolactone is classified as a potassium-sparing diuretic and aldosterone receptor antagonist. The FDA-approved labeling lists indications for heart failure, edema associated with cirrhosis, essential hypertension, and primary hyperaldosteronism. Its use for hormonal acne and hirsutism in women remains off-label, though widely supported by dermatologic guidelines [1].

Illinois Medicaid Coverage for Spironolactone

Illinois Medicaid, administered through the state's HealthChoice Illinois managed care program, covers spironolactone with prior authorization. The prior authorization requirement exists because dermatologic uses of the drug are off-label; providers must document that the patient has a qualifying diagnosis and that first-line treatments (topical retinoids, benzoyl peroxide, or oral antibiotics) were either tried or considered inappropriate.

Prior authorization approval typically takes 24 to 72 hours through the managed care organizations (MCOs) that handle pharmacy benefits in Illinois: Meridian Health Plan, Molina Healthcare, Blue Cross Community, and CountyCare in Cook County. Each MCO publishes its own preferred drug list (PDL), but generic spironolactone generally appears on all of them given its low cost and long safety record.

For Medicaid recipients, the out-of-pocket cost after PA approval is usually $0 to $3 per fill. Illinois eliminated most Medicaid copays for generic drugs in recent years, meaning many enrollees pay nothing at the pharmacy counter. The Endocrine Society's 2017 guidelines on hirsutism management recommend spironolactone as a first-line pharmacologic option for women with hirsutism, and citing this guideline in the PA request can strengthen the clinical justification.

Patients who receive a PA denial have the right to appeal. Illinois law requires MCOs to process standard appeals within 30 days and expedited appeals within 72 hours. Prescribers can also request a peer-to-peer review with the MCO's medical director, which often resolves denials faster than the formal appeals process. A 2017 systematic review published in the British Journal of Dermatology found that spironolactone reduced acne lesion counts by 50 to 100% in most female patients studied, evidence that supports off-label authorization requests [1].

Commercial Insurance and Spironolactone in Illinois

Most commercial insurance plans in Illinois place generic spironolactone on tier 1 (preferred generics), which carries the lowest copay tier. Typical tier-1 copays at Blue Cross Blue Shield of Illinois, Aetna, UnitedHealthcare, and Cigna range from $0 to $15 for a 30-day supply. Some high-deductible health plans require the patient to pay full cash price until the deductible is met, but even then, the $15 average cash-pay price is lower than many patients' copays for brand-name drugs.

Employer-sponsored plans dominate the Illinois commercial market. According to the Kaiser Family Foundation's employer health benefits survey, roughly 56% of Illinois residents under age 65 receive coverage through an employer. These plans almost universally cover spironolactone without prior authorization for its FDA-approved indications (heart failure, hypertension). For off-label dermatologic use, some plans do require PA, but many process the claim automatically because the drug is inexpensive and the plan's pharmacy benefit manager (PBM) does not flag low-cost generics for utilization review.

Illinois residents purchasing individual plans through the ACA marketplace (Get Covered Illinois) can also expect coverage. All ACA-compliant plans must cover prescription drugs as an essential health benefit, and generic spironolactone falls well within formulary norms. The question is rarely whether spironolactone is covered, but rather what the copay will be, and for a generic this old, the answer is almost always the plan's lowest tier.

Patients with both Medicare Part D and a Medigap supplement will also find spironolactone on virtually every Part D formulary. The drug's low cost means it typically falls below the coverage gap (formerly known as the "donut hole"), and many Part D plans charge $0, $5 for tier-1 generics in 2026.

Compounded Spironolactone in Illinois

Compounded spironolactone is legal in Illinois when dispensed by a pharmacy operating under a valid 503A license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications based on individual patient prescriptions, and Illinois does not impose additional state-level restrictions that would bar spironolactone compounding specifically.

Topical spironolactone compounded as a 2 to 5% cream or gel has gained interest among dermatologists who want to minimize systemic side effects (potassium elevation, diuresis, menstrual irregularity) while delivering the anti-androgen benefit directly to facial skin. A 2019 randomized controlled trial published in the Journal of Drugs in Dermatology found that topical 5% spironolactone cream reduced inflammatory lesion counts in women with hormonal acne, though the study was small (N=40) and effect sizes were modest compared to oral dosing [2].

Illinois-based 503A compounding pharmacies that prepare topical spironolactone formulations include both independent specialty pharmacies and larger regional compounders. Prices for compounded topical spironolactone typically range from $30 to $80 per month, significantly more than oral generic tablets, because compounding labor and specialized bases increase production costs. Insurance rarely covers compounded medications, so patients should expect to pay cash.

Prescribers ordering compounded spironolactone in Illinois should ensure the pharmacy holds a current Illinois Department of Financial and Professional Regulation (IDFPR) pharmacy license and complies with USP <795> standards for non-sterile compounding. The FDA's compounding policy page outlines the federal framework that governs 503A operations.

Telehealth Prescribing of Spironolactone in Illinois

Illinois permits telehealth prescribing of spironolactone statewide. The Illinois Telehealth Act, updated in 2021 and extended through subsequent legislative sessions, allows licensed physicians, nurse practitioners, and physician assistants to prescribe medications after a synchronous audio-video visit. No in-person visit is required before initiating a spironolactone prescription, though prescribers must establish a legitimate provider-patient relationship during the telehealth encounter.

This matters for acne patients in rural Illinois counties where dermatology access is limited. According to the American Academy of Dermatology's workforce data, many downstate Illinois counties have zero practicing dermatologists, creating wait times of three months or more for in-person appointments. Telehealth platforms that prescribe spironolactone for hormonal acne can cut that wait to days.

Spironolactone requires baseline lab work before initiation: a basic metabolic panel (BMP) to check potassium and renal function, and in some cases a pregnancy test, since the drug is category X and contraindicated in pregnancy [3]. Illinois telehealth prescribers typically order labs through Quest Diagnostics or Labcorp patient service centers, which are widely available across the state, or accept recent lab results from the patient's primary care provider. Follow-up potassium checks are recommended at 4 to 6 weeks after initiation and annually thereafter for patients on stable doses, per the Endocrine Society's clinical practice guidelines.

Discount Programs and Savings Cards

Several pathways exist to reduce spironolactone costs in Illinois beyond standard insurance. The most accessible is a pharmacy discount card from GoodRx, RxSaver, or SingleCare, which negotiates rates with retail pharmacies and passes the savings to uninsured or underinsured patients. These cards are free, require no enrollment, and can be used at almost every Illinois pharmacy.

Pfizer, the original manufacturer of Aldactone, does not currently offer a dedicated savings card for spironolactone because the drug is available as a low-cost generic. Manufacturer savings programs are typically reserved for brand-name products still under patent protection. Patients sometimes confuse Pfizer's general patient assistance programs with drug-specific copay cards. Pfizer's patient assistance program (Pfizer RxPathways) does cover certain medications for income-eligible patients, but generic spironolactone's low price means few patients qualify or need this level of assistance [4].

Illinois-specific programs can also help. The Illinois Rx Buying Club, administered through the Illinois Department of Healthcare and Family Services, negotiates drug pricing for state employees and retirees. County-level health departments in Cook, DuPage, and Lake counties operate pharmacy assistance programs for uninsured residents that may include generic spironolactone in their formularies.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) fills spironolactone prescriptions at cost plus a flat dispensing fee, with prices frequently below $5 for a 30-day supply. The pharmacy ships to Illinois addresses, making it a viable option for patients who can wait 3, 5 business days for mail delivery rather than picking up at a retail pharmacy.

For patients prescribed higher doses (150 to 200 mg daily for acne or hirsutism), the cost scales linearly at retail since most pharmacies price per tablet rather than per prescription. Filling 100 mg tablets and using 1.5 or 2 tablets daily is generally cheaper than filling the equivalent number of 50 mg tablets. Prescribers can optimize cost by writing for the largest available tablet strength.

Clinical Context: Why Spironolactone for Acne

Spironolactone blocks androgen receptors in the skin, reducing sebum production that drives hormonal acne in women. The drug is not FDA-approved for acne, but decades of dermatologic use and multiple observational studies support its efficacy. Layton et al. published a landmark 2017 review in the British Journal of Dermatology confirming that spironolactone at doses of 50 to 200 mg daily significantly reduces acne lesions in adult women, with response rates exceeding 50% in most cohorts studied [1].

The drug is used exclusively in female patients for acne due to its anti-androgen effects, which can cause gynecomastia and feminizing effects in males. Standard dosing starts at 25 to 50 mg daily and titrates up over 2 to 3 months based on clinical response and tolerability. Side effects include increased urination, breast tenderness, menstrual irregularity, and hyperkalemia. The hyperkalemia risk is low in young, otherwise healthy women with normal renal function, but monitoring remains standard practice [3].

Dr. Andrea Zaenglein, Professor of Dermatology at Penn State, has stated: "Spironolactone is the workhorse of hormonal acne therapy in women. It's inexpensive, well-tolerated, and effective, and we have decades of real-world safety data."

The American Academy of Dermatology's 2024 acne guidelines list spironolactone as a recommended option for adult women with hormonal acne who have not responded adequately to topical therapies or who prefer to avoid oral antibiotics [5]. This guideline endorsement strengthens prior authorization requests for both Medicaid and commercial insurance in Illinois.

A second perspective comes from the 2018 Cochrane systematic review on spironolactone for acne, which noted that while randomized controlled trial data remain limited, the consistency of observational evidence and low adverse-event rates support its use as adjunctive or standalone therapy in appropriately selected female patients [6]. The review called for larger randomized trials, a gap that the ongoing SAFA (Spironolactone for Adult Female Acne) trial in the UK aims to address.

Dose Forms and Strengths Available in Illinois

Generic spironolactone is dispensed in Illinois as oral tablets in 25 mg, 50 mg, and 100 mg strengths. All three strengths are widely stocked at retail pharmacies. A 25 mg tablet is scored for splitting, which can be useful for dose titration but is rarely cost-effective since the price difference between strengths is minimal.

No FDA-approved topical formulation of spironolactone exists in the United States. Patients seeking topical application must obtain it through a compounding pharmacy, as discussed above. An oral suspension (25 mg/5 mL) is also available for patients who cannot swallow tablets, though it costs more and is less commonly stocked.

The drug is taken with food to improve absorption and reduce gastrointestinal side effects. Twice-daily dosing (splitting the total daily dose between morning and evening) can help manage the diuretic effect, though many patients tolerate once-daily dosing at 50 to 100 mg without significant issues.